XML 41 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Reportable Segments (Tables)
3 Months Ended
Mar. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table provides certain financial information by reportable segment with a reconciliation to the consolidated totals.
Three Months Ended March 30, 2025
Packaged MeatsFresh PorkHog Production
Other (1)
Corporate (2)
Unallocated (3)
Intersegment Consolidated
(in millions)
Sales2,024 2,033 932 104 — — (1,322)$3,771 
Cost of sales1,665 1,906 919 84 — (1,322)3,262 
Selling, general and administrative expenses93 46 12 29 12 — 197 
Operating gains— — — — — (9)— (9)
Operating profit (loss)266 82 14 (29)(12)— 321 
Interest expense, net11 11 
Non-operating losses
Income from continuing operations before income taxes304 
Other segment data:
Depreciation and amortization32 27 15 — — 83 
Capital expenditures40 24 11 — — 79 
Three Months Ended March 31, 2024
Packaged MeatsFresh PorkHog Production
Other (1)
Corporate (2)
Unallocated (3)
Intersegment Consolidated
(in millions)
Sales $1,999 $1,938 $706 $114 $— $— $(1,314)$3,444 
Cost of sales1,621 1,782 868 116 — 10 (1,314)3,083 
Selling, general and administrative expenses92 47 12 32 — 199 
Operating gains— — — — — (1)— (1)
Operating profit (loss)286 110 (174)(8)(32)(18)— 163 
Interest expense, net16 16 
Non-operating gains (4)(4)
Income from continuing operations before income taxes 152 
Other segment data:
Depreciation and amortization 30 28 16 — — — 82 
Capital expenditures 41 29 11 — — 92 
________________
(1)Includes our Mexico and Bioscience operations. Our Mexico operations include the raising of hogs and production of pork products that are sold primarily to customers in Mexico. Our Bioscience operations use raw materials from hogs that we harvest to manufacture heparin products, including an active pharmaceutical ingredient that mitigates the risk of blood clots.
(2)Represents general corporate expenses for management and administration of the business.
(3)Includes certain items that we do not allocate to our segments.
Disaggregation of Revenue
The following table disaggregates our sales to customers by reportable segment and by major distribution channel.
Three Months Ended March 30, 2025
Retail (1)
Foodservice (2)
Exports (3)
Industrial (4)
Other / Unallocated (5)
Total External Sales (6)
Intersegment
Consolidated
(in millions)
Packaged Meats$1,284 $597 $31 $110 $$2,024 $— $2,024 
Fresh Pork483 59 435 266 1,246 787 2,033 
Hog Production— — — — 397 397 535 932 
Other (7)
— — — — 104 104 — 104 
Intersegment— — — — — — (1,322)(1,322)
Total$1,767 $657 $466 $376 $505 $3,771 $— $3,771 
Three Months Ended March 31, 2024
Retail (1)
Foodservice (2)
Exports (3)
Industrial (4)
Other / Unallocated (5)
Total External Sales (6)
IntersegmentConsolidated
(in millions)
Packaged Meats$1,318 $553 $31 $95 $$1,999 $— $1,999 
Fresh Pork471 53 423 255 1,203 735 1,938 
Hog Production— — — — 128 128 578 706 
Other (7)
— — — — 114 114 — 114 
Intersegment— — — — — — (1,314)(1,314)
Total$1,789 $606 $454 $350 $245 $3,444 $— $3,444 
________________
(1)Includes national and regional retailers in the U.S. such as grocery supermarket chains, independent grocers and club stores.
(2)Includes foodservice distributors, fast food and other restaurant operators, hotel chains and other institutional customers in the U.S.
(3)Includes exports from the U.S. to international retailers and wholesale distributors primarily in North America, Asia, Latin America and other emerging markets.
(4)Includes sales to industrial customers who use our raw materials in their finished goods production, including prepared meals, pharmaceutical production and pet food.
(5)Includes sales of grain, oilseeds, feed, breeding stock and market hogs, among others, in addition to external sales from our Mexico and Bioscience operations.
(6)Includes external sales from our Mexico operations of $99 million and $106 million in the three months ended March 30, 2025 and March 31, 2024, respectively. All other external sales are sourced from our U.S. operations.
(7)Includes our Mexico and Bioscience operations.